# Glimepiride (Glimepiride)

Source: https://ourhealthnetwork.com/drugs/glimepiride
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Glimepiride?

Glimepiride is a sulfonylurea. It is prescribed to treat diabetes mellitus, type 2. Across the United States, 93,000 doctors prescribe Glimepiride to approximately 895,000 Medicare patients.

## Brand names

Glimepiride

## Indications

Glimepiride is prescribed for the treatment of diabetes mellitus and type 2.

## Conditions treated

- [Diabetes Mellitus](https://ourhealthnetwork.com/conditions/diabetes-mellitus)
- [Type 2](https://ourhealthnetwork.com/conditions/type-2)

## Mechanism of action

Glimepiride primarily lowers blood glucose by stimulating the release of insulin from pancreatic beta cells. Sulfonylureas bind to the sulfonylurea receptor in the pancreatic beta-cell plasma membrane, leading to closure of the ATP-sensitive potassium channel, thereby stimulating the release of insulin.

## Drug classification

- Established Pharmacologic Class: Sulfonylurea [EPC]
- Route of administration: ORAL

## Common side effects

asthenia, dizziness, headache, nausea

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)